Today Stryker announced that enrollment in the proposed Rejuvenate and ABG II hip implant settlement program has reached 95% and the company will be following through with its commitment to resolve over 4,000 lawsuits over the recalled hip implants. Had enrollment fallen short of 95%, Stryker could have walked away from the Stryker settlement program.
This development is fulfilling for us at Searcy Denney since our commitment to Stryker victims dates prior to the recall. Searcy Denney lawyers filed the first case in the country and currently have more cases on record than any other firm in the country. Cal Warriner of our firm served on the Plaintiffs’ Steering Committee for this litigation and spearheaded the development of the scientific evidence. He also served as Co-Chair of the American Association for Justice’s (AAJ) Stryker Rejuvenate and ABG II litigation group. More importantly, he served as part of the court-appointed negotiation team that spent months hammering out this settlement.
According to Cal Warriner, “The fact that 95% of all qualified claimants chose to opt into the program speaks volumes about the quality and depth of the settlement program. It’s a great deal for most of those who unfortunately were implanted with these defective devices.”
Searcy Denney continues to represent victims who either chose to opt out of this settlement or do not qualify for the settlement. Brenda Fulmer, another Searcy Denney attorney intimately familiar with the Stryker cases said, “I anticipate we will be working on failed Rejuvenate and ABG II cases for a long time into the future.”